U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 060359
Company: AZURITY
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ERYTHROCIN STEARATE ERYTHROMYCIN STEARATE EQ 250MG BASE TABLET;ORAL Prescription None No Yes
ERYTHROCIN STEARATE ERYTHROMYCIN STEARATE EQ 125MG BASE TABLET;ORAL Discontinued None No No
ERYTHROCIN STEARATE ERYTHROMYCIN STEARATE EQ 500MG BASE TABLET;ORAL Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
06/24/1964 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
07/24/2013 SUPPL-29 Labeling-Package Insert

Label is not available on this site.

12/04/2013 SUPPL-28 Labeling-Package Insert Label (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/060359s028lbl.pdf
09/18/2009 SUPPL-27 Labeling

Label is not available on this site.

07/02/2009 SUPPL-25 Labeling

Label is not available on this site.

03/17/2004 SUPPL-22 Labeling

Label is not available on this site.

01/03/2003 SUPPL-20 Manufacturing (CMC)-Control

Label is not available on this site.

02/09/2001 SUPPL-19 Labeling

Label is not available on this site.

07/11/2000 SUPPL-18 Manufacturing (CMC)-Facility

Label is not available on this site.

10/26/2000 SUPPL-17 Labeling

Label is not available on this site.

04/20/1998 SUPPL-16 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
12/04/2013 SUPPL-28 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/060359s028lbl.pdf
Back to Top